Interview with Orlando Famá, President, Torrent Brazil
We met recently with Minister Pimentel when he launched his BrasilMaior plan, whose slogan was “Innovate to Compete. Compete to Grow.” If you had to make a recommendation to increase…
Address: R. Cônego Felipe, 365 – Taquara – Rio de Janeiro – RJ CEP: 22713-010,Brazil
Tel: (21) 2159-2600
Laboratórios Bagó do Brasil is a pharmaceutical company outlined by its competencies of innovation and vision of the future. The company is an important part of Bagó Group founded in 1934, in Argentina. Established in the country in 2002, its founders have created an organization with a solid reputation based on ethics and commitment to quality.
The slogan “Ethics at the service of Heath” holds an special place on guiding the company’s actions, and so does the premium, the priority ingredient of the organization’s roles.
With a head office and a plant in the city of Rio de Janeiro, a distribution center in Brasilia and representatives in the major centers of consumption in the country, the company develops, distributes and commercializes innovative pharmaceutical products.
With an excellence and reliability standing, the company progressively attracts more attention and the trustiness of the country’s medical class, acquiring the respect of Brazilian’s consumers.
Keflex
We met recently with Minister Pimentel when he launched his BrasilMaior plan, whose slogan was “Innovate to Compete. Compete to Grow.” If you had to make a recommendation to increase…
When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote…
As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up…
In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a different tack since arriving as one of…
What have been some of the recent milestones and achievements contributing to AstraZeneca Brazil’s status as the country’s fastest growing MNC? What happened in the last 10 years was a…
An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of hypertensives having their condition…
Yesterday the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming suggestions for the national plan against chronic…
10 days ago, your Swedish counterpart Mats Larsson made a technical visit here at ANVISA and said he had a lot to learn. What is it about ANVISA that can…
Yesterday, Minister Pimentel unveiled the Brazil Maior plan to increase competitiveness and growth across a variety of industrial sectors. If you had to give recommendations to improve the Brazilian pharmaceutical…
In the past four years, Brazil’s pharmaceutical market has more than doubled. To what do you attribute this astounding growth? In Brazil there is a strong income inequality. As the…
Sao Paulo state is responsible for some 85% of pharmaceutical production, and last week Minister Pimentel was in the city of Sao Paulo elaborating on his BrazilMaior plan with strategic…
Besins finally arrived in Brazil in 2010. In addition to introducing the company to the market, would you also elaborate on the strategic motivation behind this decision? Besins Healthcare is…
See our Cookie Privacy Policy Here
